Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition

Oncogene

Volumn 27, Issue 3, 2008, Pages 323-331

  Sheehan, K M ^a,b   Gulmann, C ^a,b   Eichler, G S ^a   Weinstein, J N ^a   Barrett, H L ^b   Kay, E W ^b   Conroy, R M ^c   Liotta, L A ^a,d   Petricoin, E F ^d,e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BEAUMONT HOSPITAL   (Ireland)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d GEORGE MASON UNIVERSITY   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Colon cancer; Microdissection; Protein microarray; Proteomics; Stroma

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

ADULT; AGED; ARTICLE; CANCER CELL; CELL LYSATE; CLINICAL ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LYMPHOCYTIC INFILTRATION; MALE; MESENCHYME CELL; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN MICROARRAY; PROTEOMICS; SIGNAL TRANSDUCTION; STROMA CELL; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; CARCINOMA; CELL PROLIFERATION; COLONIC NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; LYMPHOCYTES; MALE; MESODERM; MIDDLE AGED; NEOPLASM PROTEINS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STROMAL CELLS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

ANIMALIA;

EID: 38049184430     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210647     Document Type: Article

References (42)

1. Araujo RP, Doran C, Liotta LA, Petricoin EF. (2005). Network targeted combination therapy: a new concept in cancer treatment. Drug Discov Today 1: 425-433.
2. Bergers G, Benjamin LE. (2003). Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401-410.
3. Bhowmick NA, Neilson EG, Moses HL. (2004). Stromal fibroblasts in cancer initiation and progression. Nature 432: 332-337.
4. Breiman L. (2001). Random Forests. Machine Learning 45: 5-32.
5. Brigati C, Noonan DM, Albini A, Benelli R. (2002). Tumor and inflammatory infiltrates: friends or foes? Clin Exp Metastasis 19: 247-258.
6. Brown PO, Botstein D. (1999). Exploring the new world of the genome with DNA microarrays. Nat Genet 21: 33-37.
7. Coussens LM, Werb Z. (2002). Inflammation and cancer. Nature 420: 860-867.
8. Cristofoli G. (2006). New signals from the invasive front. Nature 441: 444-450.
9. Derycke L, Van Marck V, Depypere H, Bracke M. (2005). Molecular targets of growth, differentiation, tissue integrity, and ectopic cell death in cancer cell. Cancer Biother Radiopharm 20: 579-587.
10. De Wever O, Mareel M. (2003). Role of tissue stroma in cancer cell invasion. J Pathol 200: 429-447.
11. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR et al. (1996). Laser capture microdissection. Science 274: 998-1001.
12. Fend F, Emmert-Buck MR, Chuaqui R, Cole K, Lee J, Liotta LA et al. (1999). Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. Am J Pathol 154: 61-66.
13. Gallagher PG, Bao Y, Prorock A, Zigrino P, Nischt R, Politi V et al. (2005). Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for host-tumor interactions in metastasis. Cancer Res 65: 4134-4146.
14. Gulmann C, Sheehan KM, Kay EW, Liotta LA, Petricoin III EF. (2006). Array based proteomics: mapping of protein circuitries for diagnostics, prognostics and therapy guidance. J Pathol 208: 595-606.
15. Grunert S, Jechlinger M, Beug H. (2003). Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell 4: 657-665.
16. Jiang Y, Goldberg ID, Shi YE. (2002). Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21: 2245-2252.
17. Joyce JA. (2005). Therapeutic targeting of the tumor microenvironment. Cancer Cell 7: 513-520.
18. Kopfstein L, Christofori G. (2006). Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci 63: 449-468.
19. Lambert E, Boudot C, Kadri Z, Soula-Rothhut M, Sowa ML, Mayeux P et al. (2003). Tissue inhibitor of metalloproteinases-1 signalling pathway leading toerythro id cell survival. Biochem J 372: 767-774.
20. Liotta L, Espina V, Mehta A, Calvert V, Rosenblatt K, Geho D et al. (2003). Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 3: 317-325.
21. Liotta LA, Kohn EC. (2001). The microenvironment of the tumor-host interface. Nature 411: 375-379.
22. Littlepage LE, Werb Z. (2005). Coevolution of cancer and stromal cellular responses. Cancer Cell 7: 499-500.
23. Matrisian LM, Cunha GR, Mohla S. (2001). Epithelial-stromal interactions and tumor progression: meeting summary and future directions. Cancer Res 61: 3844-3846.
24. McCawley LJ, O'Brien P, Hudson LG. (1998). Epidermal grow factor (EGF), and scatter factor/hepatocyte (SF/HGF)-mediated keratinocyte migration is a coincident with induction of matrix metalloproteinase (MMP)-9. J Cell Physiol 176: 255-265.
25. Mueller MM, Fusenig NE. (2002). Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation 70: 486-497.
26. Nishizuka S, Charboneau L, Young L, Major S, Reinhold WC, Waltham M et al. (2003). Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci USA 100: 14229-14234.
27. Notterman DA, Alon U, Sierk AJ, Levine AJ. (2001). Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61: 3124-3130.
28. Orimo A, Weinberg RA. (2006). Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5: 1597-1601. [E-pub 2006 Aug 1].
29. Paweletz CP, Charboneau L, Bichsel VE, Simone NL, Chen T, Gillespie JW et al. (2001). Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20: 1981-1989.
30. Peinado H, Portillo F, Cano A. (2004). Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48: 365-375.
31. Sawyers C. (2004). Targeted cancer therapy. Nature 432: 294-297.
32. Sheehan KM, Calvert VS, Kay EW, Lu Y, Fishman D, Espina V et al. (2005). Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol Cell Proteomics 4: 346-355.
33. Sun Y, Sinicrope FA. (2005). Selective inhibitors of MEK1/ERK44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells. Mol Cancer Ther 4: 51-59.
34. Thiery JP. (2002). Epithelial - mesenchymal transitions in tumor progression. Nat Rev Cancer 2: 442-454.
35. Thomson EW, Newgreen DF, Tarin D. (2005a). Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65: 5991-5995.
36. Tho mso n S, Buck E, Petti F, Griffin G, Brown E, Ramnarine N et al. (2005b). Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res 65: 9455-9462.
37. Tlsty TD, Hein PW. (2001). Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 11: 54-59.
38. Tomita T, Iwata K. (1996). Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas. Dis Colon Rectum 39: 1255-1264.
39. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace Jr AJ, Kohn KW et al. (1997). An information-intensive approach to the molecular pharmacology of cancer. Science 275: 343-349.
40. Wulfkuhle JD, Aquino JA, Calvert VS, Fishman DA, Coukos G, Liotta LA et al. (2003). Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 3: 2085-2090.
41. Yang J, Mani SA, Weinberg RA. (2006). Exploring a new twist on tumor metastasis. Cancer Res 66: 4549-4552.
42. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR et al. (1997). Gene expression profiles in normal and cancer cells. Science 276: 1268-1272.